Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ImmunoPrecise and LiteVax announced a preclinical study to analyze IPA's novel SARS-CoV-2 vaccine candidates, has been granted funding by TRANSVAC2.
read more
Immunoprecise Antibodies announced the opening of its 3,200 square foot antibody production laboratory at Vancouver Island Technology Park.
read more
Wednesday, April 15, 2020
Immunoprecise Antibodies announced has entered into a research license agreement with Janssen Research & Development.
read more
Thursday, September 15, 2022
Immunologix Laboratories announced that Dr. Pierre Jolicoeur has been appointed Chief Operating Officer. A seasoned scientist and trusted operational leader, Dr. Jolicoeur will help drive strategic growth and operational excellence across the company...
read more
Thursday, February 22, 2024
Immunocore Holdings announced that it has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb to investigate Immunocore’s ImmTAC bispecific TCR (T cell receptor) candidate targeting PRAME HLA-A02, IMC-F106C, in ...
read more
Thursday, November 09, 2017
Aquila BioMedica has secured an extended agreement with UK-based biotech firm Macrophage Pharma to support its preclinical immuno-oncology programs.
read more
Immune Biosolutions announced a research collaboration and license agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
read more
Monday, December 28, 2015
ImmuCell Corporation , an animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, has entered into a Product Development & Contract Manufacture ...
read more
Thursday, February 20, 2020
Immatics Biotechnologies GmbH has entered into a strategic collaboration agreement with GSK to develop novel adoptive cell therapies targeting multiple cancer indications.
read more
Imanova has signed an agreement that grants the company the right to manufacture for distribution and on-site use [18F]MK-6240, an early stage investigational PET imaging agent.
read more
Wednesday, August 29, 2018
ImaginAb and CPDC announced they have entered into a development and manufacturing agreement for the supply of ImaginAb's clinical-phase PET imaging agent Zr-89 IAB22M2C to key global geographies.
read more
Monday, September 25, 2017
ImaginAb announced a collaboration with Boehringer Ingelheim to further develop ImaginAb's CD8 T Cell imaging technology.
read more
Friday, February 16, 2018
ImaginAb announced the appointment of Ian Wilson as the company’s Chief Operating Officer.
read more
Friday, February 26, 2016
ImageIQ, an Imaging Software and Contract Research Organization supporting preclinical research and clinical trials, have formally announced a memorandum of understanding with T3 Labs, an Atlanta-based provider of biomedical preclinical testing and ...
read more
ImaBiotech Group announced the creation of an innovative global bioanalytical CRO with Pyxant Labs Inc. Colorado Springs and Salt Lake City sites. The integration of the expertise, innovation and analytical platforms of the companies to form a ...
read more